Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1400 of 1863 entries
View as:

Penile Injection Anxiety

Phase: N/A Priority: Normal
NCT ID: NCT00582231 Org: User:
Start: 02/28/07 End: 12/31/25 Due: 12/31/26

Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04673266 Org: User:
Start: 12/14/20 End: 12/31/25 Due: 12/31/26

A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA

Phase: N/A Priority: Normal
NCT ID: NCT05515575 Org: User:
Start: 08/23/22 End: 08/31/26 Due: 08/31/27

Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT03315026 Org: User:
Start: 12/14/17 End: 10/31/25 Due: 10/31/26

Smoking Cessation Intervention for Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00575718 Org: User:
Start: 10/22/02 End: 09/18/25 Due: 09/18/26

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002515 Org: User:
Start: 10/31/92 End: 04/30/05 Due: 04/30/06

Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls

Phase: N/A Priority: Normal
NCT ID: NCT01453660 Org: User:
Start: 10/11/11 End: 10/31/25 Due: 10/31/26

Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003659 Org: User:
Start: 09/30/98 End: 05/31/09 Due: 05/31/10

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01829958 Org: User:
Start: 04/30/13 End: 04/30/26 Due: 04/30/27

The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules

Phase: N/A Priority: Normal
NCT ID: NCT00598065 Org: User:
Start: 03/31/04 End: 12/31/09 Due: 12/31/10

BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01711632 Org: User:
Start: 10/31/12 End: 08/16/24 Due: 08/16/25

Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling

Phase: N/A Priority: Normal
NCT ID: NCT03208374 Org: User:
Start: 06/27/17 End: 06/30/26 Due: 06/30/27

Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01791309 Org: User:
Start: 01/31/13 End: 03/31/15 Due: 03/31/16

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00085579 Org: User:
Start: 03/31/04 End: 03/31/05 Due: 03/31/06

Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage

Phase: N/A Priority: Normal
NCT ID: NCT01132755 Org: User:
Start: 05/31/10 End: 08/16/17 Due: 08/16/18

Registry for Esophageal and Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06558786 Org: User:
Start: 08/12/24 End: 08/12/29 Due: 08/12/30

Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

Phase: N/A Priority: Normal
NCT ID: NCT01995578 Org: User:
Start: 12/31/13 End: 09/27/23 Due: 09/27/24

Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02167854 Org: User:
Start: 06/16/14 End: 07/07/21 Due: 07/07/22

Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00580281 Org: User:
Start: 11/30/06 End: 10/31/13 Due: 10/31/14

Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00601692 Org: User:
Start: 04/30/03 End: 12/31/09 Due: 12/31/10

Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04991025 Org: User:
Start: 10/19/22 End: 10/31/25 Due: 10/31/26

A Study of Near-Infrared Fluorescence Imaging With ICG During Reconstructive Gynecologic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05071976 Org: User:
Start: 09/24/21 End: 09/24/25 Due: 09/24/26

Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo

Phase: N/A Priority: Normal
NCT ID: NCT00574392 Org: User:
Start: 11/30/06 End: 09/30/13 Due: 09/30/14

A Study of a Telemedicine Program for Older Adults With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04917848 Org: User:
Start: 06/01/21 End: 06/01/26 Due: 06/01/27

Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03082677 Org: User:
Start: 03/10/17 End: 09/02/21 Due: 09/02/22